Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1993 1
2000 1
2006 2
2010 1
2011 2
2012 2
2013 1
2014 2
2015 2
2016 2
2017 2
2018 3
2019 3
2020 1
2021 4
2022 1
2023 2
2024 3
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.
Dimopoulos MA, Voorhees PM, Schjesvold F, Cohen YC, Hungria V, Sandhu I, Lindsay J, Baker RI, Suzuki K, Kosugi H, Levin MD, Beksac M, Stockerl-Goldstein K, Oriol A, Mikala G, Garate G, Theunissen K, Spicka I, Mylin AK, Bringhen S, Uttervall K, Pula B, Medvedova E, Cowan AJ, Moreau P, Mateos MV, Goldschmidt H, Ahmadi T, Sha L, Cortoos A, Katz EG, Rousseau E, Li L, Dennis RM, Carson R, Rajkumar SV; AQUILA Investigators. Dimopoulos MA, et al. N Engl J Med. 2025 May 8;392(18):1777-1788. doi: 10.1056/NEJMoa2409029. Epub 2024 Dec 9. N Engl J Med. 2025. PMID: 39652675 Clinical Trial.
Cytomegalovirus reactivation in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy.
Hayashino K, Seike K, Masunari T, Hashida R, Oka S, Fujiwara Y, Terao T, Kitamura W, Kobayashi H, Kamoi C, Kondo T, Fujiwara H, Asada N, Ennishi D, Fujii K, Fujii N, Maeda Y. Hayashino K, et al. Among authors: masunari t. Int J Hematol. 2025 Nov;122(5):689-699. doi: 10.1007/s12185-025-04023-y. Epub 2025 Jun 17. Int J Hematol. 2025. PMID: 40526215 Free PMC article.
Treatments and Outcomes of Newly Diagnosed CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational Study.
Nato Y, Miyazaki K, Maruyama D, Takahashi H, Sunami K, Murakami S, Negoro E, Miyazawa Y, Choi I, Okada T, Takayama N, Tomita N, Momose S, Kaneda Y, Yoshida M, Gomyo H, Toyama K, Nishikori M, Saito A, Hiraga J, Masunari T, Takahashi N, Makiyama J, Suzuki T, Tsunemine H, Takizawa J, Kato T, Masaki Y, Fukuhara N, Okamoto M, Tawara I, Asano N, Ohshima K, Izutsu K, Kato K, Suzuki R, Yamaguchi M. Nato Y, et al. Among authors: masunari t. Hematol Oncol. 2025 Mar;43(2):e70047. doi: 10.1002/hon.70047. Hematol Oncol. 2025. PMID: 39937961 Free PMC article.
Comparison of Survival Outcomes Between Chimeric Antigen Receptor T-Cell Therapy Recipients With and Without Central Nervous System Involvement.
Hayashino K, Fujii N, Murakami S, Masunari T, Yoshida I, Hashida R, Oka S, Fujiwara Y, Kitamura W, Kamoi C, Kondo T, Seike K, Fujiwara H, Asada N, Ennishi D, Fujii K, Maeda Y. Hayashino K, et al. Among authors: masunari t. Clin Lymphoma Myeloma Leuk. 2025 Nov;25(11):e995-e1005. doi: 10.1016/j.clml.2025.08.001. Epub 2025 Aug 7. Clin Lymphoma Myeloma Leuk. 2025. PMID: 40858397
The Impact of Tirabrutinib Monotherapy for the Treatment of Bing-Neel Syndrome: A Multicenter Retrospective Study.
Saburi M, Masunari T, Fukuhara N, Inagaki Y, Shimura A, Imoto N, Hasegawa Y, Hagihara M, Kobayashi N, Kumekawa H, Nakazawa H, Miyazaki K, Kawakita T, Isshiki T, Katsube A, Fujisawa S, Horigome Y, Koba Y, Jinnouchi F, Sekiguchi N. Saburi M, et al. Among authors: masunari t. Am J Hematol. 2025 Oct;100(10):1912-1915. doi: 10.1002/ajh.70029. Epub 2025 Aug 2. Am J Hematol. 2025. PMID: 40751704 Free PMC article. No abstract available.
Chronic lymphoproliferative disorder with regulatory T-cell phenotype.
Kikuchi T, Katayama Y, Kubonishi S, Watanabe T, Watanabe Y, Matsuoka K, Maeda Y, Namba N, Masunari T, Nasu R, Ikeda K, Tanimoto M. Kikuchi T, et al. Among authors: masunari t. Am J Hematol. 2006 Sep;81(9):713-6. doi: 10.1002/ajh.20688. Am J Hematol. 2006. PMID: 16838340 Free article.
Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707.
Maeda Y, Nishimori H, Yoshida I, Hiramatsu Y, Uno M, Masaki Y, Sunami K, Masunari T, Nawa Y, Yamane H, Gomyo H, Takahashi T, Yano T, Matsuo K, Ohshima K, Nakamura S, Yoshino T, Tanimoto M. Maeda Y, et al. Among authors: masunari t. Haematologica. 2017 Dec;102(12):2097-2103. doi: 10.3324/haematol.2017.167742. Epub 2017 Sep 29. Haematologica. 2017. PMID: 28971899 Free PMC article. Clinical Trial.
Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan.
Tokunaga T, Shimada K, Yamamoto K, Chihara D, Ichihashi T, Oshima R, Tanimoto M, Iwasaki T, Isoda A, Sakai A, Kobayashi H, Kitamura K, Matsue K, Taniwaki M, Tamashima S, Saburi Y, Masunari T, Naoe T, Nakamura S, Kinoshita T. Tokunaga T, et al. Among authors: masunari t. Blood. 2012 Mar 22;119(12):2837-43. doi: 10.1182/blood-2011-08-374371. Epub 2012 Feb 2. Blood. 2012. PMID: 22308294 Free article.
36 results